Authors:
LOHR M
MULLER P
KARLE P
STANGE J
MITZNER S
JESNOWSKI R
NIZZE H
NEBE B
LIEBE S
SALMONS B
GUNZBURG WH
Citation: M. Lohr et al., TARGETED CHEMOTHERAPY BY INTRATUMOR INJECTION OF ENCAPSULATED CELLS ENGINEERED TO PRODUCE CYP2B1, AN IFOSFAMIDE ACTIVATING CYTOCHROME-P450, Gene therapy, 5(8), 1998, pp. 1070-1078
Citation: R. Jesnowski et al., INCREASING THE TRANSFECTION EFFICACY AND SUBSEQUENT LONG-TERM CULTUREOF RESTING HUMAN PANCREATIC DUCT EPITHELIAL-CELLS, Pancreas, 17(3), 1998, pp. 262-265
Authors:
MULLER P
KARLE P
JESNOWSKI R
SALLER R
MITZNER S
STANGE J
LIEBE S
SALMONS B
GUNZBURG WH
LOHR M
Citation: P. Muller et al., TARGETED CHEMOTHERAPY WITH ENCAPSULATED, GENETICALLY-MODIFIED CELLS ENGINEERED TO PRODUCE CYP2B1, AN IFOSFAMIDE CONVERTING-ENZYME, Gastroenterology, 114(4), 1998, pp. 2672-2672
Authors:
LOHR M
MULLER P
KARLE P
STANGE J
MITZNER S
JESNOWSKI R
NEBE B
NIZZE H
LIEBE S
SALMONS B
GUNZBURG WH
Citation: M. Lohr et al., TARGETED CHEMOTHERAPY BY INTRATUMORAL INJECTION OF ENCAPSULATED CELLSENGINEERED TO PRODUCE AN IFOSFAMIDE ACTIVATING CYTOCHROME-P450, CYP2B1, Cancer gene therapy, 4(5), 1997, pp. 303-303
Authors:
JESNOWSKI R
MULLER P
PUSCHEL K
EMMRICH J
LIEBE S
LOHR M
Citation: R. Jesnowski et al., ISOLATION, CULTIVATION AND IMMORTALIZATION OF HUMAN PANCREATIC DUCT CELLS AS AN IN-VITRO MODEL FOR CARCINOGENESIS, European journal of cell biology, 72, 1997, pp. 298-298
Citation: R. Jesnowski et al., A RAPID AND RELIABLE METHOD FOR PCR-BASED AMPLIFICATION OF CHROMOSOMAL AND MITOCHONDRIAL-DNA FROM INTACT YEAST-CELLS, Current genetics, 27(4), 1995, pp. 318-319